Single/JJ
Nucleotide/JJ
Polymorphisms/NNS
of/IN
a/DT
16/CD
kb/NN
Region/NN
on/IN
Human/JJ
Chromosome/NN
11p15.5/CD
that/DT
Includes/NNS
the/DT
H19/NN
Gene/NN
./.
====================
The/DT
H19/NN
gene/NN
,/,
located/JJ
at/IN
human/JJ
chromosome/NN
11/CD
p15.5/NN
,/,
is/VBZ
imprinted/VBN
in/IN
most/JJS
normal/JJ
human/JJ
tissues/NNS
./.
====================
However/RB
,/,
====================
imprinting/VBG
is/VBZ
often/RB
lost/VBD
in/IN
tumors/NNS
suggesting/VBG
H19/NN
is/VBZ
a/DT
putative/JJ
tumor/NN
suppressor/NN
./.
====================
We/PRP
analyzed/VBD
the/DT
single/JJ
nucleotide/NN
polymorphisms/NNS
(/(
SNPs/NNS
)/)
of/IN
a/DT
16/CD
kb/NN
region/NN
that/WDT
includes/VBZ
the/DT
H19/NN
gene/NN
and/CC
its/PRP$
imprinting/VBG
control/NN
region/NN
(/(
ICR/NN
)/)
in/IN
the/DT
Korean/JJ
population/NN
./.
====================
To/TO
identify/VB
SNPs/NNS
,/,
we/PRP
directly/RB
sequenced/VBN
this/DT
region/NN
in/IN
18/CD
Korean/JJ
subjects/NNS
./.
====================
We/PRP
identified/VBD
64/CD
SNPs/NNS
,/,
of/IN
which/WDT
7/CD
were/VBD
in/IN
the/DT
exons/NNS
of/IN
H19/NN
,/,
2/CD
were/VBD
in/IN
the/DT
introns/NNS
,/,
14/CD
were/VBD
in/IN
the/DT
3/CD
’/NN
intergenic/JJ
region/NN
and/CC
41/CD
were/VBD
in/IN
the/DT
5/CD
’/NN
intergenic/JJ
region/NN
./.
====================
Of/IN
the/DT
64/CD
SNPs/NNS
,/,
21/CD
had/VBD
not/RB
previously/RB
been/VBN
reported/VBN
and/CC
thus/RB
appear/VBP
to/TO
be/VB
unique/JJ
to/TO
the/DT
Korean/JJ
population/NN
./.
====================
The/DT
identified/VBN
SNPs/NNS
of/IN
H19/NN
in/IN
the/DT
Korean/JJ
population/NN
may/MD
eventually/RB
be/VB
useful/JJ
as/IN
genetic/JJ
markers/NNS
associated/VBN
with/IN
various/JJ
diseases/NNS
./.
====================
In/IN
this/DT
study/NN
,/,
7/CD
of/IN
the/DT
64/CD
identified/VBN
SNPs/NNS
were/VBD
at/IN
CTCF/NN
binding/NN
sites/NNS
in/IN
the/DT
ICR/NN
and/CC
may/MD
affect/VB
regulation/NN
of/IN
H19/NN
gene/NN
imprinting/VBG
./.
====================
Thus/RB
,/,
several/JJ
genetic/JJ
variations/NNS
of/IN
the/DT
H19/NN
gene/NN
may/MD
be/VB
important/JJ
markers/NNS
in/IN
human/JJ
diseases/NNS
that/IN
involve/VBP
genomic/JJ
imprinting/VBG
,/,
including/VBG
cancer/NN
./.
====================
The/DT
human/JJ
H19/NN
gene/NN
consists/VBZ
of/IN
five/CD
exons/NNS
separated/VBN
by/IN
four/CD
introns/NNS
./.
====================
Early/JJ
studies/NNS
mapped/VBD
it/PRP
to/TO
11p15.5/CD
,/,
a/DT
chromosomal/JJ
region/NN
with/IN
known/VBN
tumor/NN
suppressor/NN
activity/NN
,/,
and/CC
subsequent/JJ
analysis/NN
revealed/VBD
that/IN
H19/NN
expression/NN
is/VBZ
often/RB
altered/JJ
in/IN
several/JJ
different/JJ
types/NNS
of/IN
tumors/NNS
relative/JJ
to/TO
that/DT
in/IN
adjacent/JJ
,/,
non-transformed/JJ
cells/NNS
(/(
Chung/JJ
et/FW
al./FW
,/,
1996/CD
;/:
Cui/NNP
et/FW
al./FW
,/,
1997/CD
)/)
./.
====================
The/DT
human/JJ
sequence/NN
has/VBZ
a/DT
putative/JJ
ORF/NN
that/DT
appears/VBZ
to/TO
encode/VB
a/DT
====================
26/CD
kDa/NN
protein/NN
but/CC
the/DT
gene/NN
product/NN
appears/VBZ
to/TO
be/VB
RNA/NN
rather/RB
than/IN
a/DT
protein/NN
(/(
Hao/NN
et/FW
al./FW
,/,
1993/CD
;/:
Joubel/NNP
et/FW
al./FW
,/,
1996/CD
;/:
Pfeifer/NN
et/FW
al./FW
,/,
1996/CD
)/)
./.
====================
The/DT
H19/NN
gene/NN
is/VBZ
a/DT
known/JJ
imprinted/JJ
gene/NN
./.
====================
It/PRP
is/VBZ
expressed/VBN
exclusively/RB
from/IN
the/DT
maternal/JJ
chromosome/NN
and/CC
is/VBZ
linked/VBN
and/CC
co-regulated/VBD
with/IN
the/DT
insulin-like/JJ
growth/NN
factor/NN
2/CD
gene/NN
,/,
IGF2/NN
,/,
which/WDT
is/VBZ
also/RB
imprinted/VBD
but/CC
expressed/VBD
primarily/RB
from/IN
the/DT
paternal/JJ
chromosome/NN
(/(
Bell/NNP
etal./FW
,/,
2000/CD
)/)
./.
====================
A/DT
2/CD
kb/NN
region/NN
of/IN
differential/JJ
methylation/NN
located/JJ
from/IN
-2/CD
to/TO
-4/CD
kb/NN
relative/JJ
to/TO
the/DT
H19/NN
transcriptional/JJ
start/NN
site/NN
has/VBZ
been/VBN
proposed/VBN
to/TO
act/VB
as/IN
the/DT
imprinting/VBG
mark/VBP
(/(
Davis/NNS
etal./FW
,/,
1999/CD
)/)
./.
====================
A/DT
differentially/RB
methylated/VBN
region/NN
(/(
DMR/NN
)/)
upstream/RB
of/IN
H19/NN
has/VBZ
been/VBN
proposed/VBN
to/TO
participate/VB
in/IN
the/DT
imprinting/VBG
control/NN
of/IN
human/JJ
IGF2/NN
and/CC
H19/NN
(/(
Thorvaldsen/NNP
,/,
1998/CD
)/)
./.
====================
The/DT
DMR/NN
,/,
or/CC
imprinting/VBG
control/NN
region/NN
(/(
ICR/NN
)/)
,/,
acts/VBZ
as/IN
an/DT
epigenetic/JJ
modifier/NN
of/IN
allelic/JJ
expression/NN
by/IN
recruiting/VBG
proteins/NNS
that/WDT
specifically/RB
bind/VBP
to/TO
methylated/JJ
or/CC
unmethylated/JJ
DNA/NN
(/(
Ulaner/NN
et/FW
al./FW
,/,
2003a/CD
)/)
./.
====================
In/IN
human/JJ
,/,
the/DT
ICR/NN
contains/VBZ
seven/CD
specific/JJ
binding/NN
sites/NNS
for/IN
the/DT
zinc/NN
finger/NN
insulator/NN
protein/NN
CTCF/NN
(/(
CCCTC-binding/JJ
factor/NN
)/)
(/(
Hark/NN
etal./FW
,/,
2000/CD
)/)
./.
====================
CTCF/NN
binds/VBZ
to/TO
several/JJ
sites/NNS
in/IN
the/DT
unmethylated/JJ
ICR/NN
that/DT
are/VBP
essential/JJ
for/IN
enhancer/NN
blocking/VBG
(/(
Hark/NN
et/FW
a/DT
)/)
./.
,/,
2000/CD
)/)
./.
====================
The/DT
methylation/NN
status/NN
of/IN
binding/VBG
sites/NNS
for/IN
CTCF/NN
in/IN
the/DT
H19/NN
promoter/NN
is/VBZ
suggested/VBN
to/TO
be/VB
involved/VBN
in/IN
the/DT
regulation/NN
of/IN
imprinting/VBG
of/IN
the/DT
H19/IGF2/NN
locus/NN
(/(
Takai/NNP
etal./FW
,/,
2001/CD
)/)
./.
====================
Only/RB
the/DT
sixth/NN
of/IN
the/DT
seven/CD
CTCF-binding/JJ
sites/NNS
has/VBZ
been/VBN
demonstrated/VBN
to/TO
have/VB
allele-specific/JJ
differential/JJ
methylation/NN
(/(
Takai/NNP
etal./FW
,/,
2001/CD
)/)
./.
====================
This/DT
region/NN
contains/VBZ
well/RB
characterized/VBN
single/JJ
nucleotide/NN
polymorphisms/NNS
(/(
SNPs/NNS
)/)
which/WDT
make/VBP
it/PRP
possible/JJ
to/TO
distinguish/VB
the/DT
paternal/JJ
and/CC
maternal/JJ
alleles/NNS
(/(
Takai/NNP
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
Several/JJ
studies/NNS
have/VBP
used/VBN
two/CD
or/CC
three/CD
SNPs/NNS
within/IN
the/DT
ICR/NN
to/TO
discriminate/VB
between/IN
the/DT
two/CD
alleles/NNS
to/TO
investigate/VB
whether/IN
tumors/NNS
have/VBP
abnormal/JJ
H19/IGF2/NN
methylation/NN
(/(
Nakagawa/NN
etal./FW
,/,
2001/CD
;/:
Ulaner/NNP
et/FW
al./FW
,/,
2003a/CD
;/:
Ulaner/NNP
etal./FW
,/,
2003b/NN
)/)
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
analyzed/VBD
SNPs/NNS
in/IN
a/DT
16/CD
kb/NN
region/NN
that/WDT
includes/VBZ
the/DT
H19/NN
gene/NN
and/CC
its/PRP$
2/CD
kb/NN
ICR/NN
in/IN
the/DT
Korean/JJ
population/NN
./.
====================
Our/PRP$
results/NNS
provide/VBP
new/JJ
information/NN
about/IN
several/JJ
SNPs/NNS
that/DT
may/MD
impact/VB
imprinting/VBG
regulation/NN
./.
====================
Peripheral/JJ
blood/NN
samples/NNS
were/VBD
obtained/VBN
from/IN
18/CD
healthy/JJ
adults/NNS
(/(
8/CD
males/NNS
and/CC
10/CD
females/NNS
)/)
aged/JJ
25-43/CD
years/NNS
at/IN
the/DT
National/JJ
Genome/NN
Research/NN
Institute/JJ
in/IN
Korea/NN
./.
====================
Genomic/JJ
====================
DNA/NN
was/VBD
extracted/VBN
from/IN
blood/NN
with/IN
a/DT
QIAamp/NN
DNA/NN
Blood/NN
Kit/NN
(/(
QIAGEN/NN
,/,
Valencia/NN
,/,
CA/NNP
)/)
according/VBG
to/TO
the/DT
manufacturer/NN
’/CD
s/NNS
protocol/NN
./.
====================
The/DT
primer/NN
sets/NNS
for/IN
the/DT
PCR/NN
walking/NN
analysis/NN
are/VBP
shown/VBN
in/IN
Table/JJ
1/CD
./.
====================
The/DT
PCR/NN
reactions/NNS
contained/VBD
20/CD
ng/NN
genomic/JJ
DNA/NN
,/,
0.2/CD
units/NNS
of/IN
AmpliTaq/NN
Gold/JJ
(/(
Perkin-Elmer/NN
,/,
Weiterstadt/NNP
,/,
Germany/NNP
)/)
or/CC
LA/NN
taq/RB
(/(
Takara/NN
Bio/NNP
,/,
Otsu/NNP
,/,
Japan/NNP
)/)
polymerase/NN
,/,
1/LS
mM/NN
dNTPs/NNS
,/,
1xPCR/NN
buffer/CC
,/,
5/CD
pmol/NN
sense/NN
primer/NN
and/CC
5/CD
pmol/NN
antisense/JJ
primer/NN
in/IN
20/CD
and/CC
were/VBD
performed/VBN
in/IN
a/DT
thermal/JJ
cycler/NN
(/(
Perkin-Elmer/NN
)/)
at/IN
the/DT
following/VBG
temperatures/NNS
:/:
95°C/CD
for/IN
5/CD
min/NN
,/,
30/CD
cycles/NNS
at/IN
95/CD
C/NN
for/IN
30/CD
sec/JJ
./.
====================
at/IN
60~68°C/NN
for/IN
45/CD
sec/JJ
and/CC
at/IN
72°C/NN
for/IN
3/CD
min/NN
,/,
====================
followed/VBN
by/IN
72/CD
°C/NN
for/IN
10/CD
min/NN
./.
====================
To/TO
check/VB
the/DT
quality/NN
of/IN
the/DT
PCR/NN
products/NNS
before/IN
the/DT
sequencing/NN
reactions/NNS
,/,
one-tenth/DT
of/IN
the/DT
reaction/NN
mixture/NN
was/VBD
separated/VBN
by/IN
electrophoresis/NN
on/IN
a/DT
1/CD
%/NN
agarose/IN
gel/NN
./.
====================
The/DT
primers/NNS
used/VBN
for/IN
sequencing/NN
are/VBP
the/DT
same/JJ
as/IN
those/DT
used/VBN
for/IN
PCR/NN
(/(
Table/JJ
1/CD
)/)
./.
====================
Cycle/NN
sequencing/NN
reactions/NNS
were/VBD
performed/VBN
using/VBG
PCR/NN
product/NN
and/CC
an/DT
Applied/VBN
Biosystems/NNS
(/(
Foster/NN
City/NN
,/,
CA/NNP
)/)
Big/NN
Dye/NN
Terminator/NN
(/(
version/NN
2.0/CD
)/)
ready/RB
reaction/NN
kit/NN
./.
====================
The/DT
amount/NN
of/IN
primer/NN
in/IN
the/DT
reaction/NN
was/VBD
1/CD
pmol/NN
,/,
and/CC
total/JJ
reaction/NN
volume/NN
was/VBD
10/CD
id/JJ
./.
====================
Cycling/VBG
parameters/NNS
were/VBD
:/:
30/CD
cycles/NNS
of/IN
30/CD
sec/NN
at/IN
95/CD
°C/NN
,/,
5/CD
sec/NN
at/IN
50/CD
°C/NN
,/,
4/CD
min/NN
at/IN
60°C/NN
,/,
followed/VBN
by/IN
refrigeration/NN
until/IN
use/NN
./.
====================
Each/DT
reaction/NN
mixture/NN
was/VBD
ethanol-precipitated/VBN
to/TO
remove/VB
excess/NN
dye/NN
terminators/NNS
./.
====================
The/DT
pellets/NNS
were/VBD
dissolved/VBN
in/IN
11/CD
id/JJ
template/NN
suppression/NN
reagent/JJ
(/(
TSR/NN
,/,
Applied/VBN
Biosystems/NNS
)/)
,/,
heated/VBN
at/IN
95/CD
C/NN
C/NN
for/IN
4/CD
min/NN
to/TO
denature/JJ
,/,
quenched/VBN
on/IN
ice/RB
for/IN
4/CD
min/NN
,/,
mixed/JJ
,/,
spun/NN
briefly/RB
,/,
loaded/VBD
into/IN
the/DT
autosampler/NN
tray/RB
of/IN
an/DT
ABI3100/NN
automated/JJ
DNA/NN
sequencer/NN
,/,
and/CC
sequenced/VBN
according/VBG
to/TO
the/DT
ABI3100/NN
operator/NN
’/NNP
s/NNS
manual/JJ
./.
====================
The/DT
sequencer/NN
was/VBD
set/NN
up/IN
to/TO
run/JJ
using/VBG
POP6/NN
polymer/NN
and/CC
a/DT
36/CD
cm/NN
capillary/JJ
with/IN
30/CD
sec/NN
injection/NN
time/NN
and/CC
120/CD
min/NN
run/JJ
time/NN
./.
====================
Polymorphisms/NNS
were/VBD
detected/VBN
by/IN
multiple/JJ
alignments/NNS
of/IN
sequences/NNS
using/VBG
the/DT
Phred/Phrap//NN
Consed/JJ
package/NN
(/(
Ewing/JJ
eta//NN
./.
====================
1998/CD
;/:
Gordon/NN
etal/JJ
./.
====================
1998/CD
)/)
./.
====================
Deviation/NN
from/IN
Hardy-Weinberg/JJ
expectancy/NN
was/VBD
examined/VBN
with/IN
x/NN
2/CD
or/CC
Fisher/JJ
’/CD
s/NNS
exact/JJ
test/NN
./.
====================
Haploview/NN
software/JJ
(/(
version/NN
32/CD
)/)
was/VBD
used/VBN
for/IN
the/DT
analysis/NN
of/IN
haplotype/JJ
and/CC
tagging/VBG
SNP/NN
detection/NN
(/(
Barrett/NN
,/,
2005/CD
)/)
./.
====================
We/PRP
discovered/VBD
64/CD
SNPs/NNS
in/IN
the/DT
H19/NN
region/NN
(/(
16/CD
kb/NN
;/:
NT_009237/NN
)/)
on/IN
chromosome/NN
11p15.5/CD
in/IN
the/DT
Korean/JJ
population/NN
(/(
n=18/CD
)/)
./.
====================
This/DT
region/NN
contains/VBZ
the/DT
H19/NN
gene/NN
(/(
1.4/CD
kb/NN
)/)
,/,
the/DT
H19/NN
promoter/NN
region/NN
(/(
2/CD
kb/NN
)/)
,/,
an/DT
imprinting/VBG
control/NN
region/NN
(/(
ICR/NN
)/)
including/VBG
CTCF/NN
binding/NN
sites/NNS
(/(
2/CD
kb/NN
)/)
,/,
and/CC
an/DT
intergenic/JJ
region/NN
(/(
-10/CD
kb/NN
)/)
./.
====================
This/DT
region/NN
was/VBD
amplified/VBN
from/IN
samples/NNS
from/IN
18/CD
normal/JJ
Koreans/NNS
by/IN
using/VBG
PCR/NN
primers/NNS
(/(
Table/JJ
1/CD
)/)
./.
====================
The/DT
PCR/NN
products/NNS
were/VBD
directly/RB
sequenced/VBN
to/TO
analyze/VB
the/DT
SNPs/NNS
./.
====================
The/DT
dbSNP/NN
database/NN
in/IN
the/DT
National/JJ
Center/NN
for/IN
Biotechnology/NN
Information/NN
(/(
NCBI/NN
)/)
has/VBZ
93/CD
SNPs/NNS
in/IN
the/DT
H19/NN
region/NN
./.
====================
Of/IN
the/DT
64/CD
SNPs/NNS
that/DT
we/PRP
identified/VBD
in/IN
this/DT
region/NN
,/,
43/CD
were/VBD
identical/JJ
to/TO
SNPs/NNS
in/IN
the/DT
NCBI/NN
database/NN
./.
====================
The/DT
remaining/VBG
21/CD
were/VBD
thus/RB
judged/VBN
to/TO
be/VB
novel/JJ
in/IN
the/DT
Korean/JJ
====================
population/NN
./.
====================
Of/IN
the/DT
64/CD
SNPs/NNS
,/,
7/CD
were/VBD
in/IN
exons/NNS
and/CC
2/CD
were/VBD
in/IN
introns/NNS
(/(
none/NN
of/IN
which/WDT
were/VBD
novel/JJ
)/)
,/,
6/CD
were/VBD
in/IN
the/DT
promoter/NN
(/(
1/LS
of/IN
which/WDT
was/VBD
novel/JJ
)/)
,/,
7/CD
were/VBD
in/IN
the/DT
ICR/NN
(/(
1/LS
novel/JJ
)/)
,/,
28/CD
were/VBD
in/IN
the/DT
5/CD
’/NN
intergenic/JJ
region/NN
(/(
16/CD
novel/JJ
)/)
,/,
and/CC
14/CD
were/VBD
in/IN
the/DT
3/CD
’/NNP
intergenic/JJ
region/NN
(/(
3/LS
novel/JJ
)/)
(/(
Table/JJ
2/CD
)/)
./.
====================
We/PRP
investigated/VBD
the/DT
haplotypes/NNS
of/IN
a/DT
5.4/CD
kb/NN
region/NN
(/(
Position/NN
:/:
780559-785146/CD
,/,
Table/JJ
2/CD
)/)
with/IN
21/CD
SNPs/NNS
containing/VBG
the/DT
H19/NN
gene/NN
,/,
promoter/NN
and/CC
ICR/NN
./.
====================
The/DT
position/NN
784496/CD
SNP/NN
(/(
minimal/JJ
allele/NN
frequency/NN
</JJR
5/CD
%/NN
)/)
was/VBD
omitted/VBN
./.
====================
The/DT
patterns/NNS
of/IN
haplotype/JJ
structure/NN
and/CC
frequencies/NNS
in/IN
this/DT
5.4/CD
kb/NN
gene/NN
region/NN
are/VBP
shown/VBN
in/IN
Table/JJ
3/CD
./.
====================
There/EX
were/VBD
8/CD
common/JJ
haplotypes/NNS
(/(
frequency/NN
5/CD
%/NN
)/)
and/CC
11/CD
tagging/VBG
SNPs/NNS
were/VBD
found/VBN
./.
====================
We/PRP
also/RB
selected/VBN
4/CD
SNPs/NNS
(/(
rs2839698/CD
,/,
rs2251375/NN
,/,
rs2071095/NN
,/,
rs4930103/NN
)/)
that/WDT
were/VBD
present/JJ
in/IN
both/DT
our/PRP$
data/NNS
and/CC
the/DT
HapMap/NN
database/NN
(/(
The/DT
International/JJ
HapMap/NN
Consortium./NNP
,/,
2004/CD
)/)
and/CC
analyzed/VBD
the/DT
haplotype/JJ
diversity/NN
and/CC
frequency/NN
(/(
Table/JJ
4/CD
)/)
./.
====================
The/DT
frequencies/NNS
of/IN
haplotype/JJ
1/CD
-4/CD
in/IN
the/DT
Korean/JJ
population/NN
were/VBD
similar/JJ
with/IN
those/DT
in/IN
the/DT
Japanese/JJ
and/CC
Chinese/JJ
populations/NNS
but/CC
different/JJ
from/IN
the/DT
frequency/NN
in/IN
the/DT
CEPH/NN
population/NN
(/(
Utah/NNP
residents/NNS
with/IN
ancestry/NN
from/IN
northern/NN
and/CC
western/NN
Europe/NN
)/)
./.
====================
Haplotype/NN
5/CD
was/VBD
the/DT
common/JJ
haplotype/NN
in/IN
the/DT
Korean/JJ
population/NN
,/,
====================
but/CC
was/VBD
not/RB
found/VBN
in/IN
the/DT
Japanese/JJ
,/,
Chinese/JJ
,/,
and/CC
CEPH/NN
populations/NNS
(/(
Table/JJ
4/CD
)/)
./.
====================
Thus/RB
we/PRP
find/VBP
that/IN
several/JJ
SNPs/NNS
and/CC
haplotypes/NNS
in/IN
the/DT
Korean/JJ
population/NN
differ/VBP
from/IN
those/DT
in/IN
other/JJ
ethnic/JJ
groups/NNS
./.
====================
We/PRP
only/RB
found/VBN
64/CD
SNPs/NNS
in/IN
this/DT
region/NN
compared/VBD
with/IN
the/DT
93/CD
in/IN
the/DT
NCBI/NN
database/NN
./.
====================
This/DT
may/MD
be/VB
due/JJ
to/TO
our/PRP$
small/JJ
sample/NN
size/NN
(/(
n=18/CD
)/)
./.
====================
Detection/NN
of/IN
89/CD
%/NN
of/IN
polymorphic/JJ
sites/NNS
(/(
minimal/JJ
allele/NN
frequency/NN
of/IN
5/CD
%/NN
)/)
would/MD
require/VB
n=16/NN
,/,
and/CC
detection/NN
of/IN
99/CD
%/NN
would/MD
require/VB
n=48/CD
(/(
Kruglyak/JJ
et/FW
a/./FW
,/,
2001/CD
)/)
./.
====================
In/IN
our/PRP$
case/NN
,/,
with/IN
n=18/NN
,/,
we/PRP
expect/VBP
to/TO
detect/VB
over/IN
99/CD
%/NN
of/IN
SNPs/NNS
with/IN
a/DT
minimal/JJ
allele/NN
frequency/NN
of/IN
20/CD
%/NN
./.
====================
Thus/RB
we/PRP
do/VBP
not/RB
expect/VB
to/TO
detect/VB
low/JJ
frequency/NN
SNPs/NNS
in/IN
our/PRP$
sample/NN
./.
====================
In/IN
addition/NN
this/DT
discrepancy/NN
in/IN
SNP/NN
detection/NN
raises/VBZ
the/DT
possibility/NN
of/IN
invalid/JJ
or/CC
extremely/RB
low/JJ
frequency/NN
SNPs/NNS
in/IN
the/DT
public/JJ
databases/NNS
and/CC
underlines/NNS
the/DT
need/NN
to/TO
check/VB
the/DT
validity/NN
and/CC
frequency/NN
of/IN
any/DT
potential/JJ
marker/NN
SNPs/NNS
in/IN
an/DT
intended/JJ
study/NN
population/NN
./.
====================
The/DT
ICR/NN
of/IN
H19/NN
is/VBZ
methylated/VBN
from/IN
-2/CD
to/TO
-4/CD
kb/NN
relative/JJ
to/TO
the/DT
start/NN
of/IN
transcription/NN
./.
====================
CTCF/NN
binding/NN
was/VBD
recently/RB
shown/VBN
to/TO
play/VB
a/DT
direct/JJ
role/NN
in/IN
inhibiting/VBG
methylation/NN
of/IN
the/DT
ICR/NN
in/IN
order/NN
to/TO
establish/VB
and/CC
maintain/VBP
imprinting/VBG
of/IN
the/DT
Igf2/H19/NN
region/NN
,/,
and/CC
CTCF/NN
binding/NN
sites/NNS
were/VBD
shown/VBN
to/TO
be/VB
dispensable/JJ
for/IN
initiating/VBG
imprinting/VBG
(/(
Szabo/NN
eta/./FW
,/,
2004/CD
)/)
./.
====================
The/DT
methylation/NN
status/NN
of/IN
this/DT
region/NN
was/VBD
ascertained/VBN
by/IN
bisulfite/NN
conversion/NN
and/CC
methylation-specific/JJ
PCR/NN
(/(
Ulaner/NN
et/FW
al./FW
,/,
2003b/NN
)/)
./.
====================
The/DT
paternal/JJ
allele/NN
is/VBZ
methylated/VBN
and/CC
the/DT
maternal/JJ
allele/NN
is/VBZ
unmethylated/VBN
./.
====================
The/DT
SNPs/NNS
allow/VBP
distinction/NN
of/IN
the/DT
paternal/JJ
and/CC
maternal/JJ
alleles/NNS
./.
====================
Of/IN
the/DT
six/CD
SNPs/NNS
in/IN
the/DT
ICR/NN
that/DT
were/VBD
previously/RB
reported/VBD
,/,
two/CD
(/(
785015/CD
(/(
C/T/NN
)/)
and/CC
785104/CD
(/(
G/T/NN
)/)
)/)
were/VBD
previously/RB
analyzed/VBD
for/IN
allelic/JJ
expression/NN
based/VBN
on/IN
the/DT
methylation/NN
status/NN
(/(
Ulaner/NN
et/FW
al./FW
,/,
2003b/NN
)/)
./.
====================
Bisulfite/NN
DNA/NN
sequencing/NN
revealed/VBD
a/DT
C/T/NN
polymorphism/NN
at/IN
base/NN
785015/CD
(/(
an/DT
A/G/NN
polymorphism/NN
at/IN
base/NN
6325/CD
;/:
accession/NN
no/DT
./.
====================
AF087017/CD
)/)
./.
====================
The/DT
allele/NN
containing/VBG
the/DT
A/NN
polymorphism/NN
was/VBD
methylated/VBN
,/,
whereas/IN
the/DT
allele/NN
containing/VBG
the/DT
G/NN
polymorphism/NN
was/VBD
unmethylated/VBN
./.
====================
In/IN
addition/NN
,/,
Poon/NN
et/FW
al/JJ
./.
====================
(/(
2002/CD
)/)
reported/VBD
that/IN
paternally/RB
inherited/VBN
methylated/VBN
H19/NN
fetal/JJ
alleles/NNS
were/VBD
different/JJ
from/IN
the/DT
methylated/JJ
alleles/NNS
of/IN
the/DT
respective/JJ
mothers/NNS
using/VBG
a/DT
C/T/NN
polymorphism/NN
at/IN
base/NN
785015/CD
./.
====================
This/DT
raised/VBD
the/DT
possibility/NN
of/IN
using/VBG
epigenetic/JJ
markers/NNS
for/IN
the/DT
specific/JJ
detection/NN
of/IN
fetal/JJ
DNA/NN
in/IN
maternal/JJ
plasma/NN
./.
====================
Furthermore/RB
,/,
only/RB
the/DT
sixth/NN
CTCF/NN
binding/NN
site/NN
showed/VBD
allele-specific/JJ
methylation/NN
(/(
Takai/NNP
eta/./FW
,/,
2001/CD
)/)
./.
====================
The/DT
785146/CD
(/(
A/G/NN
)/)
site/NN
is/VBZ
====================
located/JJ
at/IN
the/DT
sixth/NN
CTCF/NN
binding/NN
site/NN
./.
====================
This/DT
SNP/NN
site/NN
may/MD
act/VB
as/IN
a/DT
marker/NN
for/IN
regulating/VBG
H19/NN
expression/NN
./.
====================
Nakayashiki/NN
et/FW
al/JJ
./.
====================
(/(
2004/CD
)/)
recently/RB
described/VBN
three/CD
closely/RB
located/JJ
SNPs/NNS
(/(
g/a/NN
g7523a/NN
,/,
g/a/NN
g7547a/NN
,/,
c/t/JJ
c7591t/NN
;/:
accession/NN
no/DT
./.
====================
AF125183/NN
)/)
and/CC
designated/VBN
them/PRP
as/IN
the/DT
H19FR/NN
haplotype/NN
./.
====================
They/PRP
were/VBD
able/JJ
to/TO
selectively/RB
discriminate/VB
the/DT
parental/JJ
alleles/NNS
by/IN
enzymatically/RB
digesting/VBG
differentially/RB
methylated/VBN
genomic/JJ
DNA/NN
./.
====================
This/DT
method/NN
could/MD
be/VB
useful/JJ
for/IN
identifying/VBG
the/DT
parental/JJ
origin/NN
of/IN
alleles/NNS
./.
====================
However/RB
,/,
these/DT
three/CD
SNPs/NNS
were/VBD
not/RB
present/JJ
in/IN
the/DT
Korean/JJ
population/NN
./.
====================
In/IN
any/DT
case/NN
,/,
SNPs/NNS
located/JJ
in/IN
the/DT
ICR/NN
should/MD
provide/VB
information/NN
about/IN
the/DT
methylation/NN
status/NN
determined/VBN
by/IN
expression/NN
of/IN
H19/NN
alleles/NNS
./.
====================
In/IN
addition/NN
,/,
information/NN
on/IN
the/DT
methylation/NN
status/NN
of/IN
the/DT
H19/NN
gene/NN
may/MD
help/VB
to/TO
understand/VB
how/WRB
imprinting/VBG
is/VBZ
disrupted/VBN
in/IN
tumors/NNS
./.
====================
Numerous/JJ
studies/NNS
have/VBP
revealed/VBN
abnormal/JJ
imprinting/VBG
of/IN
H19/NN
in/IN
a/DT
wide/JJ
range/NN
of/IN
tumors/NNS
(/(
Nakagawa/NN
eta/./FW
,/,
2001/CD
;/:
Ulaner/NNP
etal./FW
,/,
2003a/CD
;/:
Manoharan/NNP
etal./FW
,/,
2003/CD
;/:
Yin/NN
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
Loss/NN
of/IN
imprinting/VBG
(/(
LOI/NN
)/)
of/IN
IGF2/NN
correlated/VBD
strongly/RB
with/IN
biallelic/JJ
hypermethylation/NN
in/IN
a/DT
core/NN
region/NN
of/IN
an/DT
H19-associated/JJ
CTCF-binding/JJ
site/NN
(/(
Nakagawa/NN
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
The/DT
presence/NN
of/IN
this/DT
methylation-dependent/JJ
LOI/NN
in/IN
both/DT
tumors/NNS
and/CC
normal/JJ
colonic/JJ
mucosa/NN
indicates/VBZ
that/IN
hypermethylation/NN
may/MD
create/VB
a/DT
field/NN
defect/NN
predisposing/VBG
to/TO
cancer/NN
(/(
Nakagawa/NN
eta/./FW
,/,
2001/CD
)/)
./.
====================
In/IN
addition/NN
,/,
incomplete/JJ
gain/NN
or/CC
loss/NN
of/IN
methylation/NN
at/IN
this/DT
CTCF-/NN
binding/VBG
site/NN
during/IN
tumorigenesis/NN
can/MD
explain/VB
the/DT
complex/NN
and/CC
conflicting/VBG
expression/NN
patterns/NNS
of/IN
IGF2/NN
and/CC
H19/NN
in/IN
a/DT
tumor/NN
(/(
Ulaner/NN
etal./FW
,/,
2003a/CD
)/)
./.
====================
Manoharan/JJ
etal/JJ
./.
====================
(/(
2003/CD
)/)
used/VBN
a/DT
SNP/NN
marker/NN
in/IN
the/DT
H19/NN
coding/VBG
sequence/NN
to/TO
investigate/VB
H19/NN
imprinting/VBG
./.
====================
They/PRP
found/VBN
monoallelic/JJ
expression/NN
of/IN
the/DT
maternal/JJ
gene/NN
in/IN
fetal/JJ
liver/NN
,/,
but/CC
biallelic/JJ
expression/NN
in/IN
liver/NN
neoplasms/NNS
,/,
thus/RB
demonstrating/VBG
the/DT
basis/NN
for/IN
the/DT
deregulation/NN
of/IN
the/DT
imprinted/JJ
gene/NN
expression/NN
during/IN
hepatocarcinogenesis/NN
./.
====================
The/DT
imprinting/VBG
of/IN
IGF2/H19/NN
is/VBZ
similar/JJ
to/TO
DLK1/GTL2/NN
,/,
another/DT
reciprocally/RB
imprinted/JJ
gene/NN
pair/NN
./.
====================
The/DT
imprinting/VBG
status/NN
of/IN
DLK1/NN
in/IN
brain/NN
tumors/NNS
and/CC
lymphomas/NNS
has/VBZ
also/RB
been/VBN
deduced/VBN
by/IN
analysis/NN
of/IN
a/DT
SNP/NN
(/(
Yin/NN
etal./FW
,/,
2004/CD
)/)
./.
====================
We/PRP
propose/VBP
that/IN
the/DT
polymorphic/JJ
sites/NNS
of/IN
H19/NN
are/VBP
good/JJ
genomic/JJ
markers/NNS
for/IN
imprinting/VBG
studies/NNS
of/IN
additional/JJ
tumor/NN
types/NNS
./.
====================
H19/NN
was/VBD
one/CD
of/IN
the/DT
first/JJ
imprinted/JJ
genes/NNS
to/TO
be/VB
identified/VBN
in/IN
mice/NNS
and/CC
humans/NNS
./.
====================
It/PRP
is/VBZ
an/DT
excellent/JJ
model/NN
for/IN
studies/NNS
of/IN
genomic/JJ
imprinting/VBG
because/IN
it/PRP
is/VBZ
a/DT
representative/JJ
imprinting/VBG
gene/NN
in/IN
human/JJ
and/CC
other/JJ
animals/NNS
./.
====================
In/IN
the/DT
mouse/NN
,/,
monoallelic/JJ
expression/NN
of/IN
H19/NN
is/VBZ
regulated/VBN
by/IN
an/DT
ICR/NN
located/JJ
at/IN
chromosome/NN
7/CD
(/(
Thorvaldsen/NNP
etal./FW
,/,
1998/CD
)/)
and/CC
CTCF/NN
binding/VBG
has/VBZ
been/VBN
shown/VBN
to/TO
have/VB
a/DT
role/NN
at/IN
four/CD
sites/NNS
in/IN
the/DT
IGF2/H19/NN
ICR/NN
(/(
Szabo/NNP
etal./FW
,/,
2004/CD
;/:
Schoenherr/NNP
etal./FW
,/,
2003/CD
;/:
Thorvaldsen/NNP
etal./FW
,/,
2002/CD
)/)
./.
====================
A/DT
mutation/NN
in/IN
the/DT
mouse/NN
CTCF/NN
site/NN
4/CD
was/VBD
sufficient/JJ
to/TO
cause/VB
robust/JJ
activation/NN
of/IN
the/DT
maternal/JJ
Igf2/NN
allele/NN
and/CC
to/TO
disturb/VB
the/DT
methylation-free/JJ
status/NN
of/IN
the/DT
maternal/JJ
H19/NN
ICR/NN
allele/NN
(/(
Pant/JJ
etal./FW
,/,
2004/CD
)/)
./.
====================
H19/NN
is/VBZ
also/RB
imprinted/VBD
in/IN
cattle/NN
,/,
in/IN
which/WDT
the/DT
maternal/JJ
allele/NN
was/VBD
found/VBN
to/TO
be/VB
predominantly/RB
or/CC
exclusively/RB
expressed/VBN
in/IN
all/DT
tissues/NNS
examined/VBN
(/(
Zhang/NNP
etal./FW
,/,
2004/CD
)/)
./.
====================
Identification/NN
of/IN
a/DT
SNP/NN
in/IN
the/DT
bovine/JJ
H19/NN
gene/NN
made/VBD
it/PRP
possible/JJ
to/TO
study/VB
its/PRP$
imprinting/VBG
status/NN
by/IN
following/VBG
the/DT
expression/NN
of/IN
parental/JJ
alleles/NNS
in/IN
heterozygous/JJ
animals/NNS
./.
====================
The/DT
present/JJ
results/NNS
will/MD
help/VB
to/TO
analyze/VB
sequences/NNS
and/CC
SNPs/NNS
of/IN
the/DT
H19/NN
region/NN
in/IN
other/JJ
mammals/NNS
(/(
e.g./FW
,/,
pig/NN
and/CC
sheep/NN
)/)
./.
====================
The/DT
SNPs/NNS
that/DT
we/PRP
identified/VBD
can/MD
be/VB
used/VBN
as/IN
markers/NNS
for/IN
the/DT
study/NN
of/IN
developmental/JJ
abnormalities/NNS
./.
====================
The/DT
SNPs/NNS
of/IN
the/DT
H19/NN
gene/NN
discovered/VBN
in/IN
this/DT
study/NN
should/MD
be/VB
useful/JJ
as/IN
genomic/JJ
markers/NNS
for/IN
imprinting/VBG
studies/NNS
./.
====================
Particularly/RB
,/,
they/PRP
should/MD
be/VB
useful/JJ
as/IN
markers/NNS
in/IN
types/NNS
of/IN
tumors/NNS
that/WDT
involve/VBP
genomic/JJ
imprinting/VBG
./.
====================
We/PRP
are/VBP
planning/VBG
a/DT
case-control/JJ
study/NN
of/IN
cancer/NN
using/VBG
the/DT
SNPs/NNS
discovered/VBN
in/IN
the/DT
Korean/JJ
population/NN
./.
====================
